Publicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (16)

2024

  1. Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin

    Chemico-Biological Interactions, Vol. 391

2023

  1. The pattern of histone H3 epigenetic posttranslational modifications is regulated by the VRK1 chromatin kinase

    Epigenetics and Chromatin, Vol. 16, Núm. 1

  2. VRK1 variants at the cross road of Cajal body neuropathogenic mechanisms in distal neuropathies and motor neuron diseases

    Neurobiology of Disease, Vol. 183

2019

  1. VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes

    Scientific Reports, Vol. 9, Núm. 1

2016

  1. VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1863, Núm. 4, pp. 760-769

2013

  1. Sensitivity of the kinase activity of human vaccinia-related kinase proteins to toxic metals

    Journal of Biological Inorganic Chemistry, Vol. 18, Núm. 4, pp. 473-482

2011

  1. Substrate profiling of human vaccinia-related kinases identifies coilin, a Cajal body nuclear protein, as a phosphorylation target with neurological implications

    Journal of Proteomics, Vol. 75, Núm. 2, pp. 548-560

2010

  1. Cancer as a reprogramming-like disease: Implications in tumor development and treatment

    Seminars in Cancer Biology, Vol. 20, Núm. 2, pp. 93-97

  2. VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer

    Molecular and Cellular Biology, Vol. 30, Núm. 19, pp. 4687-4697

2008

  1. Proteomics identification of nuclear Ran GTPase as an inhibitor of human VRK1 and VRK2 (Vaccinia-related kinase) activities

    Molecular and Cellular Proteomics, Vol. 7, Núm. 11, pp. 2199-2214

2007

  1. Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations

    Archives of Biochemistry and Biophysics, Vol. 465, Núm. 1, pp. 219-226

  2. Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1

    Molecular and Cellular Biology, Vol. 27, Núm. 20, pp. 7273-7283

2006

  1. Vaccinia virus B1R kinase interacts with JIP1 and modulates c-Jun-dependent signaling

    Journal of Virology, Vol. 80, Núm. 15, pp. 7667-7675

2005

  1. Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation

    Leukemia, Vol. 19, Núm. 8, pp. 1376-1383

2002

  1. Transient activation of the c-Jun N-terminal kinase (JNK) activity by ligation of the tetraspan CD53 antigen in different cell types

    European Journal of Biochemistry, Vol. 269, Núm. 3, pp. 1012-1021

2000

  1. Amplification of human genomic sequences by human papillomaviruses universal consensus primers

    Journal of Virological Methods, Vol. 87, Núm. 1-2, pp. 171-175